Diabetes in Europe: An update

Diabetes Research and Clinical Practice

Volumn 103, Issue 2, 2014, Pages 206-217

  Tamayo, T ^a   Rosenbauer, J ^a   Wild, S H ^b   Spijkerman, A M W ^c   Baan, C ^c   Forouhi, N G ^d   Herder, C ^a   Rathmann, W ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diabetes; IDF Diabetes Atlas; IDF Europe Region; Prevalence; Risk factors

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; DEATH CERTIFICATE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; EUROPE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PASSIVE SMOKING; PHYSICAL DISABILITY; PHYSICAL INACTIVITY; POLLUTANT; POPULATION DISTRIBUTION; PREVALENCE; QUALITY OF LIFE; RISK FACTOR; SOCIAL PSYCHOLOGY; SOCIAL STATUS; ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; FEMALE; INCIDENCE; INFANT; LIFESTYLE; MALE; NEWBORN; PRESCHOOL CHILD; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIFE STYLE; MALE; PREVALENCE; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 84895832362     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.11.007     Document Type: Article

References (169)

1. IDF Diabetes Atlas 2013, International Diabetes Federation, Brussels, Belgium. 6th ed.
2. Satman I., Omer B., Tutuncu Y., Kalaca S., Gedik S., Dinccag N., et al. TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013, 28:169-180.
3. World Health Organisation Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO consultation 1999, WHO, Geneva.
4. Satman I., Yilmaz T., Sengül A., Salman S., Salman F., Uygur S., et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002, 25:1551-1556.
5. Whiting, Guariguata L., Weil C., Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
6. World Health Organization Diabetes mellitus: report of a WHO Study Group. World Health Organ Tech Rep Ser 1985, 727:1-113.
7. World Health Organization World health statistics 2011 2011, WHO Press, Geneva.
8. Thefeld W. Prevalence of diabetes mellitus in the adult German population. Gesundheitswesen 1999, 61:85-89.
9. Heidemann C., Du Y., Schubert I., Rathmann W., Scheidt-Nave C. Prävalenz und zeitlicheEntwicklung des bekannten Diabetes mellitus. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013, 56(5-6):668-677.
10. Soriguer F., Goday A., Bosch-Comas A., Bordiú E., Calle-Pascual A., Carmena R., et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the diabetes study. Diabetologia 2012, 55(1):88-93.
11. IDF Diabetes Atlas 2011, International Diabetes Federation, Brussels, Belgium. 5th ed.
12. Pajak A. Myocardial infarction and complications longitudinal observation of a population of 280,000 women and men - Project POL-MONICA Krakow. I. Genesis and objectives of the WHO MONICA Project. Przegl Lek 1996, 53:703-706. [in Polish].
13. Łopatyński J., Mardarowicz G., Nicer T., Szcześniak G., Król H., Matej A., et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland). Pol Arch Med Wewn 2001, 106:781-786.
14. Polakowska M., Piotrowski W. Incidence of diabetes in the Polish population: results of the Multicenter Polish Population Health Status Study - WOBASZ. Pol Arch Med Wewn 2011, 121:156-163.
15. Gardete-Correia L., Boavida J.M., Raposo J.F., Mesquita A.C., Fona C., Carvalho R., et al. First diabetes prevalence study in Portugal: PREVADIAB study. Diabet Med 2010, 27:879-881.
16. Gourdy P., Ruidavets J.B., Ferrieres J., Ducimetiere P., Amouyel P., Arveiler D., et al. Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions - the MONICA study 1995-97. Diabetes Metab 2001, 27:347-358.
17. Bringer J., Fontaine P., Detournay B., Nachit-Ouinekh F., Brami G., Eschwege E. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study. Diabetes Metab 2009, 35:25-31.
18. Bonaldi C., Vernay M., Roudier C., Salanave B., Oleko A., Malon A., et al. A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007. Diabet Med 2011, 28:583-589.
19. Cricelli C., Mazzaglia G., Samani F., Marchi M., Sabatini A., Nardi R., et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003, 25:254-257.
20. Estoppey D., Paccaud F., Vollenweider P., Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health 2011, 11:114.
21. Vamos E.P., Kopp M.S., Keszei A., Novak M., Mucsi I. Prevalence of diabetes in a large, nationally representative population sample in Hungary. Diabetes Res Clin Pract 2008, 81:e5-e8.
22. Doupis J., Tentolouris N., Mastrokostopoulos A., Kokkinos A., Doupis C., Zdrava A., et al. Prevalence of type 2 diabetes in the southwest Albanian adult population. Rural Remote Health 2007, 7:744.
23. Dogadin S.A., Mashtakov B.P., Taranushenko T.E. Prevalence of type 2 diabetes in northern populations of Siberia. Int J Circumpolar Health 2001, 60:205-210.
24. King H., Abdullaev B., Djumaeva S., Nikitin V., Ashworth L., Dobo M.G. Glucose intolerance and associated factors in the Fergana Valley, Uzbekistan. Diabet Med 1998, 15:1052-1062.
25. Saaristo T.E., Barengo N.C., Korpi-Hyövälti E., Oksa H., Puolijoki H., Saltevo J.T., et al. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health 2008, 29:423.
26. DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26:61-69.
27. Metelko Z., Pavlić-Renar I., Poljicanin T., Szirovitza L., Turek S. Prevalence of diabetes mellitus in Croatia. Diab Res Clin Pract 2008, 81:263-267.
28. van'tRiet E., Alssema M., Rijkelijkhuizen J.M., Kostense P.J., Nijpels G., Dekker J.M. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010, 33:61-66.
29. Rathmann W., Haastert B., Icks A., Löwel H., Meisinger C., Holle R., et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening: the KORA survey 2000. Diabetologia 2003, 46:182-189.
30. Schipf S., Werner A., Tamayo T., Holle R., Schunk M., Maier W., et al. Regional differences in the prevalence of known type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med 2012, 29:e88-e95.
31. Meisinger C., Heier M., Völzke H., Löwel H., Mitusch R., Hense H.W., et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens 2006, 24:293-299.
32. Stang A., Döring A., Völzke H., Moebus S., Greiser K.H., Werdan K., et al. Regional differences in body fat distributions among people with comparable body mass index: a comparison across six German population-based surveys. Eur J Cardiovasc Prev Rehabil 2011, 18:106-114.
33. Ylihärsilä H., Lindström J., Eriksson J.G., Jousilahti P., Valle T.T., Sundvall J., et al. Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland. Diabet Med 2005, 22:88-91.
34. Congdon P. Estimating diabetes prevalence by small area in England. J Public Health 2006, 28:71-81.
35. Maier W., Holle R., Hunger M., Peters A., Meisinger C., Greiser K.H., et al. The Diabetes Collaborative Research of Epidemiologic Studies (DIAB-CORE) consortium. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med 2013, 30:e78-e86.
36. Carlsson A.C., Wändell P.E., Hedlund E., Walldius G., Nordqvist T., Jungner I., et al. Country of birth-specific and gender differences in prevalence of diabetes in Sweden. Diabetes Res Clin Pract 2013, 100:404-408.
37. Angyamang C., Kunst A.E., Bhopal R., Anujuo K., Zaninotto P., Nazroo J., et al. Diabetes prevalence in populations of South Asian Indian and African origins: a comparison of England and the Netherlands. Epidemiology 2011, 22:563-567.
38. Patterson C.C., Guariguata L., Dahlquist G., Soltesz G., Ogle G.D., Silink M. Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 2013, (in press).
39. Patterson C.C., Dahlquist G.G., Gyürüs E., Green A., Soltész G. EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373:2027-2033.
40. Patterson C.C., Gyürüs E., Rosenbauer J., Cinek O., Neu A., Schober E., et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012, 55:2142-2147.
41. Cinek O., Kulich M., Sumnik Z. The incidence of type 1 diabetes in young Czech children stopped rising. Pediatr Diabetes 2012, 13:559-563.
42. Berhan Y., Waernbaum I., Lind T., Möllsten A., Dahlquist G. Swedish Childhood Diabetes Study Group. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011, 60:577-581.
43. Harjutsalo V., Sund R., Knip M., Groop P.H. Incidence of type 1 diabetes in Finland. JAMA 2013, 310:427-428.
44. Kyvik K.O., Nystrom L., Gorus F., Songini M., Oestman J., Castell C., et al. The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004, 47:377-384.
45. Dahlquist G.G., Nyström L., Patterson C.C. Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group. Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: an analysis of time trends. Diabetes Care 2011, 34:1754-1759.
46. Bruno G., Novelli G., Panero F., Perotto M., Monasterolo F., Bona G., et al. Piedmont Study Group for Diabetes Epidemiology. The incidence of type 1 diabetes is increasing in both children and young adults in Northern Italy: 1984-2004 temporal trends. Diabetologia 2009, 52:2531-2535.
47. Imkampe A.K., Gulliford M.C. Trends in type 1 diabetes incidence in the UK in 0- to 14-year-olds and in 15- to 34-year-olds, 1991-2008. Diabet Med 2011, 28:811-814.
48. Lammi N., Blomstedt P.A., Moltchanova E., Eriksson J.G., Tuomilehto J., Karvonen M. Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland. Diabetologia 2008, 51:897-899.
49. Patterson C.C., Dahlquist G., Soltész G., Green A. EURODIAB ACE Study Group. Europe and diabetes is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001, 44(Suppl. 3):B9-B16.
50. Bluestone J.A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
51. Hermann R., Knip M., Veijola R., Simell O., Laine A.P., Akerblom H.K., et al. FinnDiane Study Group. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure?. Diabetologia 2003, 46:420-425.
52. Gillespie K.M., Bain S.C., Barnett A.H., Bingley P.J., Christie M.R., Gill G.V., et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004, 364:1699-1700.
53. Fourlanos S., Varney M.D., Tait B.D., Morahan G., Honeyman M.C., Colman P.G., et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008, 31:1546-1549.
54. Ziegler A.G., Meier-Stiegen F., Winkler C., Bonifacio E. TEENDIAB Study Group. Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty-TEENDIAB: study design. Pediatr Diabetes 2012, 13:419-424.
55. Knip M. Descriptive epidemiology of type 1 diabetes-is it still in?. Diabetologia 2012, 55:1227-1230.
56. Dahlquist G. Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia 2006, 49:20-24.
57. Ludvigsson J. Why diabetes incidence increases - a unifying theory. Ann N Y Acad Sci 2006, 1079:374-382.
58. Wilkin T.J. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001, 44:914-922.
59. Stene L.C., Rønningen K.S., Undlien D.E., Joner G. Does the relative risk for type 1 diabetes conferred by HLA-DQ INS, and PTPN22 polymorphisms vary with maternal age, birth weight, or cesarean section?. Pediatr Diabetes 2011, 12:91-94.
60. Bonifacio E., Warncke K., Winkler C., Wallner M., Ziegler A.G. Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 2011, 60:3300-3306.
61. Cardwell C.R., Stene L.C., Ludvigsson J., Rosenbauer J., Cinek O., Svensson J., et al. Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care 2012, 35:2215-2225.
62. Patelarou E., Girvalaki C., Brokalaki H., Patelarou A., Androulaki Z., Vardavas C. Current evidence on the associations of breastfeeding, infant formula, and cow's milk introduction with type 1 diabetes mellitus: a systematic review. Nutr Rev 2012, 70:509-511.
63. Cardwell C.R., Stene L.C., Joner G., Bulsara M.K., Cinek O., Rosenbauer J., et al. Birth order and childhood type 1 diabetes risk: a pooled analysis of 31 observational studies. Int J Epidemiol 2011, 40:363-374.
64. Cardwell C.R., Stene L.C., Joner G., Bulsara M.K., Cinek O., Rosenbauer J., et al. Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes 2010, 59:486-494.
65. Cardwell C.R., Stene L.C., Joner G., Davis E.A., Cinek O., Rosenbauer J., et al. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia 2010, 53:641-651.
66. Cardwell C.R., Stene L.C., Joner G., Cinek O., Svensson J., Goldacre M.J., et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 2008, 51:726-735.
67. Yeung W.C., Rawlinson W.D., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011, 342:d35.
68. Hara N., Alkanani A.K., Ir D., Robertson C.E., Wagner B.D., Frank D.N., et al. The role of the intestinal microbiota in type 1 diabetes. Clin Immunol 2013, 146:112-119.
69. Beyan H., Wen L., Leslie R.D. Guts, germs, and meals: the origin of type 1 diabetes. Curr Diab Rep 2012, 12:456-462.
70. Atkinson M.A., Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 2012, 55:2868-2877.
71. Mohr S.B., Garland C.F., Gorham E.D., Garland F.C. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008, 51:1391-1398.
72. Cooper J.D., Smyth D.J., Walker N.M., Stevens H., Burren O.S., Wallace C., et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011, 60:1624-1631.
73. Kolb H., Elliott R.B. Increasing incidence of IDDM a consequence of improved hygiene?. Diabetologia 1994, 37:729.
74. Howard S.G., Lee D.H. What is the role of human contamination by environmental chemicals in the development of type 1 diabetes?. J Epidemiol Community Health 2012, 66:479-481.
75. Howard S.G. Comment on: Berhan. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011, 60:577-581.
76. Prokofyeva E., Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res 2012, 47:171-188.
77. Ruta L.M., Magliano D.J., Lemesurier R., Taylor H.R., Zimmet P.Z., Shaw J.E. Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries. Diabet Med 2013, 30:387-398.
78. Yau J.W., Rogers S.L., Kawasaki R., Lamoureux E.L., Kowalski J.W., Bek T., et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012, 35:556-564.
79. Wandell P.E., Gafvels C. Patients with type 2 diabetes aged 35-64 years at four primary health care centres in Stockholm County, Sweden. Prevalence and complications in relation to gender and socio-economic status. Diabetes Res Clin Pract 2004, 63:195-203.
80. Santos Bueso E., Fernández-Vigo J., Fernández Pérez C., Macarro Merino A., FernándezPerianes J. Prevalence of diabetic retinopathy in the Regional Community of Extremadura 1997-2001 (Extremadura Project to Prevent Blindness). Arch Soc Esp Oftalmol 2005, 80:187-194. [in Spanish].
81. Detournay B., Cros S., Charbonnel B., Grimaldi A., Liard F., Cogneau J., et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab 2000, 26:363-369.
82. Happich M., Breitscheidel L., Meisinger C., Ulbig M., Falkenstein P., Benter U., et al. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study. Curr Med Res Opin 2007, 23:1367-1374.
83. Assogba G.F., Couchoud C., Roudier C., Pornet C., Fosse S., Romon I., et al. Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007). Diabetes Metab 2012, 38:558-566.
84. Rodriguez-Poncelas A., Garre-Olmo J., Franch-Nadal J., Diez-Espino J., Mundet-Tuduri X., Barrot-De la Puente J., et al. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrol 2013, 14:46.
85. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69:2057-2063.
86. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 2006, 6:479-483.
87. Registry E.-E. ERA-EDTA registry annual report 2011 2013, Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands.
88. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
89. Beghi E., Monticelli M.L. Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy Italian General Practitioner Study Group (IGPSG). Acta Neurol Scand 1997, 96:223-228.
90. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998, 41:1263-1269.
91. Delcourt C., Vauzelle-Kervroedan F., Cathelineau G., Papoz L. Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. CODIAB-INSERM-ZENECA Pharma Study Group. J Diabetes Complications 1998, 12:88-95.
92. Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C., et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia 1996, 39:1377-1384.
93. Veglio M., Sivieri R. Prevalence of neuropathy in IDDM patients in Piemonte, Italy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes, Piemonte Affiliate. Diabetes Care 1993, 16:456-461.
94. Ziegler D., Gries F.A., Muhlen H., Rathmann W., Spuler M., Lessmann F. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabetes Metab 1993, 19:143-151.
95. Fedele D., Comi G., Coscelli C., Cucinotta D., Feldman E.L., Ghirlanda G., et al. A multicenter study on the prevalence of diabetic neuropathy in Italy Italian Diabetic Neuropathy Committee. Diabetes Care 1997, 20:836-843.
96. Verhoeven S., van Ballegooie E., Casparie A.F. Impact of late complications in type 2 diabetes in a Dutch population. Diabet Med 1991, 8:435-438.
97. Kumar S., Ashe H.A., Parnell L.N., Fernando D.J., Tsigos C., Young R.J., et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994, 11:480-484.
98. Walters D.P., Gatling W., Mullee M.A., Hill R.D. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992, 9:349-353.
99. Herman W.H., Aubert R.E., Engelgau M.M., Thompson T.J., Ali M.A., Sous E.S., et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med 1998, 15:1045-1051.
100. Rith-Najarian S.J., Stolusky T., Gohdes D.M. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992, 15:1386-1389.
101. Shaw J.E., Hodge A.M., de Courten M., Dowse G.K., Gareeboo H., Tuomilehto J., et al. Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes Res Clin Pract 1998, 42:131-139.
102. Bongaerts B.W., Rathmann W., Kowall B., Herder C., Stöckl D., Meisinger C., et al. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care 2012, 35:1891-1893.
103. Bongaerts B.W., Rathmann W., Heier M., Kowall B., Herder C., Stöckl D., et al. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study. Diabetes Care 2013, 36:1141-1146.
104. Ringborg A., Lindgren P., Martinell M., Yin D.D., Schon S., Stalhammar J. Prevalence and incidence of type 2 diabetes and its complications 1996-2003 - estimates from a Swedish population-based study. Diabet Med 2008, 25(10):1178-1186.
105. Almdal T., Scharling H., Jensen J.S., Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164:1422-1426.
106. Schramm T.K., Gislason G.H., Kober L., Rasmussen S., Rasmussen J.N., Abildstrom S.Z., et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008, 117:1945-1954.
107. Giorda C.B., Avogaro A., Maggini M., Lombardo F., Mannucci E., Turco S., et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007, 38:1154-1160.
108. Avogaro A., Giorda C., Maggini M., Mannucci E., Raschetti R., Lombardo F., et al. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 2007, 30:1241-1247.
109. Wong E., Backholer K., Harding J., Gearon E., Stevenson C., Freak-Poli R., et al. A systematic review and meta-analysis of diabetes and risk of physical disability and functional impairment - protocol. Syst Rev 2012, 1:47.
110. Schunk M., Reitmeir P., Schipf S., VölzkeH, Meisinger C., Thorand B., et al. Health-related quality of life in subjects with and without type 2 diabetes: pooled analysis of five population-based surveys in Germany. Diabet Med 2012, 29:646-653.
111. Zhang X., Norris S.L., Chowdhury F.M., Gregg E.W., Zhang P. The effects of interventions on health-related quality of life among persons with diabetes: a systematic review. Med Care 2007, 45:820-834.
112. Fenwick E.K., Xie J., Ratcliffe J., Pesudovs K., Finger R.P., Wong T.Y., et al. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci 2012, 53:677-684.
113. Gregg E.W., Cheng Y.J., Saydah S., Cowie C., Garfield S., Geiss L., et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012, 35:1252-1257.
114. Olafsdottir E., Aspelund T., Sigurdsson G., Benediktsson R., Thorsson B., Harris T.B., et al. Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies. BMC Public Health 2013, 13:36.
115. Nwaneri C., Bowen-Jones D., Cooper H., Chikkaveerappa K., Afolabi B.A. Falling mortality rates in type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based study. Postgrad Med J 2012, 88:679-683.
116. Gulliford M.C., Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing?. Am J Epidemiol 2009, 169:455-461.
117. Kowall B., Rathmann W., Heier M., Giani G., Peters A., Thorand B., et al. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol 2011, 26:637-645.
118. Livingstone S.J., Looker H.C., Hothersall E.J., Wild S.H., Lindsay R.S., Chalmers J., et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012, 9:e1001321.
119. Jørgensen M.E., Almdal T.P., Carstensen B. Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 2013, 56:2401-2404.
120. Haapio M., Helve J., Groop P.H., Grönhagen-Riska C., Finne P. Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007. Diabetes Care 2010, 33:1718-1723.
121. Harjutsalo V., Forsblom C., Groop P.H. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ 2011, 343:d5364.
122. Manderbacka K., Peltonen R., Koskinen S., Martikainen P. The burden of diabetes mortality in Finland 1988-2007 - a brief report. BMC Public Health 2011, 11:747.
123. Walker J.J., Livingstone S.J., Colhoun H.M., Lindsay R.S., McKnight J.A., Morris A.D., et al. Scottish Diabetes Research Network Epidemiology Group. Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care 2011, 34:1127-1132.
124. Rao Ch., Doi S.A.R. Measuring population-based diabetes-related mortality: a summary of requirements. J Clin Epidemiol 2013, 66:237-238.
125. OECD Health at a glance: Europe 2012 2012, OECD Publishing.
126. Gillies C.L., Abrams K.R., Lambert P.C., Cooper N.J., Sutton A.J., Hsu R.T., et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007, 334:299.
127. InterAct Consortium, Langenberg C., Sharp S., Forouhi N.G., Franks P.W., Schulze M.B., et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC study. Diabetologia 2011, 54:2272-2282.
128. InterAct consortium Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct study. Diabetologia 2012, 55:1944-1952.
129. TNS Opinion & Social Special Eurobarometer 334 (Wave 72.3): sport and physical activity 2010, European Commission, Brussels.
130. InterAct Consortium, Romaguera D., Guevara M., Norat T., Langenberg C., Forouhi N.G., et al. Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care 2011, 34:1913-1918.
131. Cooper A.J., Forouhi N.G., Ye Z., Buijsse B., Arriola L., Balkau B., et al. Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr 2012, 66:1082-1092.
132. Sluijs I., Forouhi N.G., Beulens J.W., van der Schouw Y.T., Agnoli C., Arriola L., et al. On behalf of the InterAct Consortium. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct study. Am J Clin Nutr 2012, 96:382-390.
133. Patel P.S., Forouhi N.G., Kuijsten A., et al. The prospective association between total and type of fish intake and type 2 diabetes in 8 European countries: EPIC-InterAct study. Am J Clin Nutr 2012, 95:1445-1453.
134. InterAct Consortium Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. PLoS ONE 2012, 7:e36910.
135. InterAct Consortium Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia 2013, 56:47-59.
136. InterAct Consortium Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2012, 56:1520-1530.
137. InterAct Consortium The association between dietary energy density and type 2 diabetes in Europe: results from the EPIC-InterAct study. PLoS ONE 2013, 8:e59947.
138. Sluijs I., Beulens J.W., van der Schouw Y.T., van der A.D.L., Buckland G., Kuijsten A., et al. Dietaryglycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries. J Nutr 2013, 143:93-99.
139. Morris A.P., Voight B.F., Teslovich T.M., Ferreira T., Segrè A.V., Steinthorsdottir V., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012, 44:981-990.
140. Herder C., Kowall B., Tabak A.G., Rathmann W. The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia 2013, [Epub ahead of print].
141. Willi C., Bodenmann P., Ghali W.A., Faris P.D., Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007, 12:2654-2664.
142. Wang Y., Ji J., Liu Y.J., Deng X., He Q.Q. Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. PLoS ONE 2013, 26:e69915.
143. Behl M., Rao D., Aagaard K., Davidson T.L., Levin E.D., Slotkin T.A., et al. Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review. Environ Health Perspect 2013, 121:170-180.
144. Sacerdote C., Ricceri F., Rolandsson O., Baldi I., Chirlaque M.D., Feskens E., et al. Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study. Int J Epidemiol 2012, 41:1162-1173.
145. Pouwer F., Kupper N., Adriaanse M.C. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med 2010, 9:112-118.
146. Fransson E.I., Heikkilä K., Nyberg S.T., Zins M., Westerlund H., Westerholm P., et al. Job strain as a risk factor for leisure-time physical inactivity: an individual-participant meta-analysis of up to 170,000 men and women: the IPD-Work Consortium. Am J Epidemiol 2012, 176:1078-1089.
147. Rotella F., Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013, 74:31-37.
148. Rajagopalan S., Brook R.D. Air pollution and type 2 diabetes: mechanistic insights. Diabetes 2012, 61:3034-3037.
149. Richardson E.A., Pearce J., Tunstall H., Mitchell R., Shortt N.K. Particulate air pollution and health inequalities: a Europe-wide ecological analysis. Int J Health Geogr 2013, 12:34.
150. Taylor K.W., Novak R.F., Anderson H.A., Birnbaum L.S., Blystone C., Devito M., et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect 2013, 121:774-783.
151. Sattar N., Wannamethee S.G., Forouhi N.G. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?. Diabetologia 2008, 51:926-940.
152. Herder C., Karakas M., Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 2011, 90:52-66.
153. The Saint Vincent Declaration on diabetes care and research in Europe. Acta Diabetol 1989, 10(Suppl.):143-144.
154. Felton A.-M., Hall M.S. Diabetes - from St. Vincent to Glasgow. Have we progressed in 20 years?. Br J Diab Vasc Dis 2009, 9:142-144.
155. Scheller-Kreinsen D., Blumel M., Busse R. Chronic disease management in Europe. EuroHealth 2009, 15(1):1-4.
156. Elissen A.M.J., Steuten L.G.M., Lemmens L.C., Drewes H.W., Lemmens K.M.M., Baan C.A., et al. Meta-analysis of the effectiveness of chronic care management for diabetes: investigating heterogeneity in outcomes. J Eval Clin Pract 2013, 19(5):753-762.
157. Clar C., Barnard K., Cummins E., Royle P., Waugh N. Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010, 14:1-140.
158. Polisena J., Tran K., Cimon K., Hutton B., McGill S., Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab 2009, 11:913-930.
159. Campbell S., Reeves D., Kontopantelis E. Quality of primary care in England with the introduction of pay for performance. N Engl J Med 2007, 357:181-190.
160. Struijs J.N., Baan C.A. Integrating care through bundled payments - lessons from the Netherlands. N Engl J Med 2011, 264(11):990-991.
161. Raaijmakers L.G.M., Hamers F.J.M., Martens M.K., Bagchus C., de Vries N.K., Kremers S.P.J. Perceived facilitators and barriers in diabetes care: a qualitative study among health care professionals in the Netherlands. BMC Fam Pract 2013, 14:114.
162. Cunningham S., McAlpine R., Leese G., Brennan G., Sullivan F., Connacher A., et al. Using web technology to support population-based diabetes care. J Diab Sci Technol 2011, 5:523-534.
163. Di Iorio C.T., Carinci F., Brillante M., Azzopardi J., Beck P., Bratina N., et al. Cross-border flow of health information: is 'privacy by design' enough? Privacy performance assessment in EUBIROD. Eur J Public Health 2013, 23:247-253.
164. Saunders C., Byrne C.D., Guthrie B., Lindsay R.S., McKnight J.A., Philip S., et al. External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?. Diabet Med 2013, 30:300-308.
165. Paschou S.A., Leslie R.D. Personalizing guidelines for diabetes management: twilight or dawn of the expert?. BMC Med 2013, 11:161.
166. Hughes L.D., McMurdo M.E., Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing 2013, 42:62-69.
167. Zhang P., Zhang X., Brown J., Vistisen D., Sicree R., Shaw J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301.
168. Govan L., Wu O., Briggs A., Colhoun H.M., McKnight J.A., Morris A.D., et al. Scottish Diabetes Research Network Epidemiology Group. Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2011, 54:2000-2008.
169. de Bruin S.R., Heijink R., Lemmens L.C., Struijs J.N., Baan C.A. Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: a systematic review of the literature. Health Policy 2011, 105-121.